News Headlines Article

A new way: Foundation lines up generic heart drug for multiple sclerosis trial
San Francisco Business Times

A generic high blood pressure drug could unlock a new treatment window for multiple sclerosis patients in a groundbreaking study championed by a Bay Area nonprofit. The Myelin Repair Foundation of Saratoga in the next few months will launch a Phase I safety trial of the drug, approved two decades ago to treat hypertension, said President and CEO Scott Johnson.